These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7004797)

  • 41. Hemodynamic effects of intravenous labetalol in essential hypertension.
    Dunn FG; Oigman W; Messerli FH; Dreslinski GR; Reisin E; Frohlich ED
    Clin Pharmacol Ther; 1983 Feb; 33(2):139-43. PubMed ID: 6822026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. I.v. labetalol in the treatment of hypertension following coronary-artery surgery.
    Morel DR; Forster A; Suter PM
    Br J Anaesth; 1982 Nov; 54(11):1191-6. PubMed ID: 7138722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of hypertension in acute stage of myocardial infarction. Haemodynamic effects of labetalol.
    Renard M; Rivière A; Jacobs P; Bernard R
    Br Heart J; 1983 Jun; 49(6):522-7. PubMed ID: 6849714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous labetalol versus sodium nitroprusside for treatment of hypertension postcoronary bypass surgery.
    Cruise CJ; Skrobik Y; Webster RE; Marquez-Julio A; David TE
    Anesthesiology; 1989 Dec; 71(6):835-9. PubMed ID: 2686494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease.
    Silke B; Nelson GI; Ahuja RC; Taylor SH
    Br Heart J; 1982 Oct; 48(4):364-71. PubMed ID: 7126388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid onset of action of oral labetalol in severe hypertension.
    Ghose RR; Sampson A
    Curr Med Res Opin; 1977; 5(2):147-51. PubMed ID: 340130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic effects at rest and during exercise of combined alpha/beta-receptor blockade and of beta-receptor blockade alone in patients with ischemic heart disease.
    Koch G; Fransson L
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):474-8. PubMed ID: 2444802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.
    Bahlmann J; Brod J; Hubrich W; Cachovan M; Pretschner P
    Br J Clin Pharmacol; 1979; 8(Suppl 2):113S-117S. PubMed ID: 526390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haemodynamic effects of glucagon.
    Murtagh JG; Binnion PF; Lal S; Hutchison KJ; Fletcher E
    Br Heart J; 1970 May; 32(3):307-15. PubMed ID: 5420074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulatory responses to thiopentone and tracheal intubation in patients with coronary artery disease. Effects of pretreatment with labetalol.
    Fischler M; Dubois C; Brodaty D; Schlumberger S; Melchior JC; Guilmet D; Vourc'h G
    Br J Anaesth; 1985 May; 57(5):493-6. PubMed ID: 3888239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response of the systemic and pulmonary circulation to alpha- and beta-receptor blockade (labetalol) at rest and during exercise in hypertensive patients.
    Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
    Circulation; 1979 Dec; 60(6):1214-7. PubMed ID: 40708
    [No Abstract]   [Full Text] [Related]  

  • 53. Hemodynamic effects of labetalol in healthy volunteers.
    Allonen H; Kanto J; Pakkanen A; Wendelin H
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):517-9. PubMed ID: 7174154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effectiveness and hemodynamic mechanism of action of blood pressure lowering by intravenous labetalol in patients with a critical increase in blood pressure].
    Schuster HP; Ehlers B; Bodmann KF; Köhler F
    Klin Wochenschr; 1989 Jul; 67(14):723-9. PubMed ID: 2770185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies.
    Scardo JA; Vermillion ST; Newman RB; Chauhan SP; Hogg BB
    Am J Obstet Gynecol; 1999 Oct; 181(4):862-6. PubMed ID: 10521743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of labetalol on intracranial pressure in dogs with and without intracranial hypertension.
    Van Aken H; Puchstein C; Schweppe ML; Heinecke A
    Acta Anaesthesiol Scand; 1982 Dec; 26(6):615-9. PubMed ID: 7158271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The effect of combined alpha and beta blockade with labetalol on the haemodynamics of stress reaction in hypertensives (author's transl)].
    Bahlmann J; Brod J; Hubrich W; Pretschner P
    Dtsch Med Wochenschr; 1980 Oct; 105(41):1414-8. PubMed ID: 7449643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Labetalol infusion in acute myocardial infarction with systemic hypertension.
    Marx PG; Reid DS
    Br J Clin Pharmacol; 1979; 8(Suppl 2):233S-238S. PubMed ID: 526407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.
    Lund-Johansen P; Bakke OM
    Br J Clin Pharmacol; 1979 Feb; 7(2):169-74. PubMed ID: 760749
    [No Abstract]   [Full Text] [Related]  

  • 60. Study of single and multiple dose pharmacokinetic/pharmacodynamic modeling of the antihypertensive effects of labetalol.
    Maronde RF; Robinson D; Vlachakis ND; Barr JW; Chung M; Zampaglione N; Medakovic M
    Am J Med; 1983 Oct; 75(4A):40-6. PubMed ID: 6356898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.